Six biotech companies developing treatment and monitoring of heart disease are investing ideas that five advisors highlight.
from Forbes Real Time http://www.forbes.com/sites/moneyshow/2017/08/03/heart-felt-buys-6-cardiac-opportunities/
via IFTTT
No comments:
Post a Comment